je.st
news
Tag: advanced
STUDER S11 Cylindrical Grinder Wins Advanced Manufacturing Award
2014-06-03 06:00:00| Industrial Newsroom - All News for Today
MIAMISBURG, Ohio – At the recent global MACH 2014 manufacturing technology exhibition in Birmingham, England, Metal Working Production magazine awarded Fritz Studer AG the gold medal in the "Best Grinding/Finishing Equipment" category for the S11 production cylindrical grinding machine. In conjunction with the exhibition, the manufacturing trade publication presents its MWP Advanced Manufacturing Awards for innovative products in every aspect of metalworking engineering and ...This story is related to the following:Materials and Material ProcessingSearch for suppliers of: Grinding Machinery
Tags: advanced
award
manufacturing
wins
Data on Mercks Pembrolizumab from Largest Study to Date of Investigational Anti-PD-1 Antibody in Advanced Melanoma Highlighted at ASCO 2014
2014-06-02 13:30:00| Merck.com - Corporate News
Dateline City: CHICAGO Pembrolizumab as Monotherapy Shows Estimated Overall Survival Rate of 69 Percent at One Year Across 411 Advanced Melanoma Patients with Varying Stages of Disease and Prior Therapy Durable Responses and Consistent Tolerability Profile Observed Across Doses, Including Patients With or Without Prior Ipilimumab Therapy Phase 3 Trials Ongoing or Planned Across Lines of Therapy, Including Adjuvant Treatment CHICAGO--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced new data from the companys large ongoing Phase 1b study (KEYNOTE-001) evaluating pembrolizumab (MK-3475), Mercks investigational anti-PD-1 antibody, as a single agent (monotherapy) in 411 patients with advanced melanoma. Language: English Contact: MerckMedia:Ian McConnell, 973-901-5722orClaire Mulhearn, 908-423-7425orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: date
data
advanced
study
First Presentation of Data for Pembrolizumab, Mercks Investigational Anti-PD-1 Antibody, in Patients with Previously-Untreated, Advanced Non-Small Cell Lung Cancer (NSCLC) at ASCO 2014
2014-06-02 13:30:00| Merck.com - Corporate News
Dateline City: CHICAGO Initial Therapy with Pembrolizumab Demonstrates Robust Anti-Tumor Activity with Tumor Shrinkage in 80 Percent of Evaluable PD-L1 Positive, Advanced NSCLC Patients Merck Initiating Phase 3 Study with Pembrolizumab Versus Platinum-Based Doublet Chemotherapy as First-Line Therapy in PD-L1 Positive, Advanced NSCLC (KEYNOTE-024) Additional 50 Patients Enrolled in KEYNOTE-001 with Analyses Planned Using Mercks Proprietary PD-L1 Assay at One Percent and 50 Percent Cut Points CHICAGO--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of data evaluating pembrolizumab (MK-3475), Mercks investigational anti-PD-1 antibody, as initial therapy in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC). Language: English Contact: MerckMedia Contacts:Ian McConnell, (973) 901-5722orClaire Mulhearn, (908) 423-7425orInvestor Contacts:Carol Ferguson, (908) 423-4465orJustin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
advanced
cell
presentation
Linde to Showcase Advanced Technologies at BIO International Convention 2014
2014-06-02 06:00:00| Industrial Newsroom - All News for Today
VERISEQ® Nucleation controls pharmaceutical freeze drying processes<br /> <br /> Linde Cryoservices™ program to cryogenically store irreplaceable specimens<br /> <br /> MURRAY HILL NEW PROVIDENCE, N.J. – Linde North America, Inc. will be featuring technologies at BIO International Convention 2014 that will help pharmaceutical manufacturers and biotech companies meet production and environmental requirements. The convention will take place at San Diego Convention Center in San ...
Tags: international
advanced
technologies
bio
"Super Panel" and Advanced In-Vehicle Connectivity Solutions Headline Visteon ...
2014-06-02 06:00:00| Industrial Newsroom - All News for Today
Automotive Supplier Introduces In-Vehicle 4G LTE Connectivity<br /> <br /> VAN BUREN TOWNSHIP, Mich. — Visteon Corporation (NYSE: VC) will showcase its latest in-vehicle connectivity solutions and discuss the auto-mobility revolution June 4-5 at Telematics Detroit 2014 in Novi, Michigan. Attendees can experience the latest advancements at Visteon's booth (#27) and hear from technology experts, including Global Director of Innovation and Design Tim Yerdon. Yerdon will join executives from ...This story is related to the following:ServicesSoftwareSearch for suppliers of: Automotive Electronics | Networking Software |
Tags: advanced
super
solutions
panel
Sites : [314] [315] [316] [317] [318] [319] [320] [321] [322] [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] next »